Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphocytic, Chronic, B-Cell

Explore clinical trials studying Leukemia, Lymphocytic, Chronic, B-Cell. Study availability and eligibility vary by location and protocol.

1,435 public trials 165 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphocytic, Chronic, B-Cell trial results

Completed

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

NCT00910910

Conditions
B-cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
Locations
  • California Cancer Associates for Research and Excellence cCARE Escondido, California, United States
  • Innovative Clinical Research Institute Whittier, California, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Cancer Center of Central Connecticut Southington, Connecticut, United States
View all 165 locations
View Trial Details
Completed

Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia

NCT00634881

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany
  • Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany
  • Universitatsklinikum Heidelberg Heidelberg, Germany
  • Klinikum Lippe - Lemgo Lemgo, Germany
View Trial Details
Completed

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT01008462

Conditions
B-Cell Prolymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +51 more
Locations
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
  • Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
View Trial Details
Completed

Rituximab, Fludarabine, and Cyclophosphamide or Observation Alone in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia

NCT00275054

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Universitaetsklinik fuer Innere Medizin I Vienna, Austria
  • Centre Hospitalier Universitaire d'Amiens Amiens, France
  • Centre Hospitalier Regional et Universitaire d'Angers Angers, France
  • Centre Hospitalier Victor Dupouy Argenteuil, France
View all 91 locations
View Trial Details
Completed

Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

NCT00262795

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hanuschkrankenhaus Vienna, Austria
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Zentralklinikum Augsburg Augsburg, Germany
View all 88 locations
View Trial Details
Completed

Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia

NCT00276848

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Hanuschkrankenhaus Vienna, Austria
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Internistische Praxis - Arnstadt Arnstadt, Germany
View all 135 locations
View Trial Details
Completed

Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia

NCT00274989

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Internistische Praxis - Arnstadt Arnstadt, Germany
  • Klinikum Augsburg Augsburg, Germany
  • HELIOS Klinikum Bad Saarow Bad Saarow, Germany
  • Internistische Gemeinschaftspraxis - Berlin Berlin, Germany
View all 58 locations
View Trial Details
Completed

Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

NCT00392691

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland
View Trial Details

Related conditions